Automated Reinforcement Management Systems, Phase II

Part of paid clinical trials in Spokane, Washington.

Sponsor
Washington State University
Study ID
NCT06456905
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Contingency Management — BEHAVIORAL
    Participants in the contingent group will be rewarded on an incrementally increasing scale for submitting consecutive breathalyzer samples that are 0.00%. For every day this target is met, the participant will receive an increase in reward until a daily cap is reached. If a day contains at least one sample where the target is not met, the participant will not be paid for that day, and the amount will reset. The participant will have the opportunity to earn on this scale throughout the duration of the study.

Study Details

The Automated Reinforcement Management Systems Phase II (ARMS II) study is a phase II trial is a randomized controlled, non-medicated assisted trial to determine the effectiveness of Contingency Management (CM) treatment for reducing alcohol drinking among adults who want to quit or reduce their alcohol consumption.

Key Dates

Start date
Jun 7, 2024
Status verified
Aug 2024
Primary completion
Sep 1, 2025
Completion
Sep 1, 2025

Study Design

Enrollment
125 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Contingency Management + Treatment As Usual
    An experimental approach examining the effectiveness of contingency management for promoting a decrease in drinking through increasing rewards for positive behavior. Participants will be given positive reinforcement messaging regardless of the sample's results.
  • No Intervention: Non-Contingent Management + Treatment As Usual
    Participants will be given a flat amount for submitting samples on time, and there is no increasing scale for maintaining samples at 0.00%BAC. Participants will be given positive reinforcement messaging regardless of the sample's results.

Primary Outcome Measure

Change in days abstinent [ Time Frame: 45 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington State UniversitySpokaneWashington99202
Abigail L Bowen, MS
[email protected]
425-736-1354

Find similar trials in Spokane, WA

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
Washington State University· Spokane, WA

Related Studies